domperidone has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 7 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty-four patients (10 male, 74 female) whose investigation of hyperprolactinaemia included a domperidone test and high resolution pituitary MRI." | 7.69 | An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia. ( Bevan, JS; Robb, OJ; Sawers, HA; Shaw, J; Strachan, FM; Walmsley, D, 1997) |
| "These results suggestthat in PES with prolactinoma the inhibiting dopaminergic tone is increased on the thyrotropic cells and reduced on the lactotropic cells in PES with elevated PRL and that some patients with PES might bear a microprolactinoma in the bottom of the sella which remained undetected by the CT scan." | 5.29 | TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome. ( Attali, JR; Combes, ME; Perret, G; Valensi, P, 1996) |
| "Eighty-four patients (10 male, 74 female) whose investigation of hyperprolactinaemia included a domperidone test and high resolution pituitary MRI." | 3.69 | An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia. ( Bevan, JS; Robb, OJ; Sawers, HA; Shaw, J; Strachan, FM; Walmsley, D, 1997) |
| "These results suggestthat in PES with prolactinoma the inhibiting dopaminergic tone is increased on the thyrotropic cells and reduced on the lactotropic cells in PES with elevated PRL and that some patients with PES might bear a microprolactinoma in the bottom of the sella which remained undetected by the CT scan." | 1.29 | TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome. ( Attali, JR; Combes, ME; Perret, G; Valensi, P, 1996) |
| "Microprolactinoma is a particular pathological situation characterized by the presence of increased hypothalamic dopaminergic tone reactive to tumoral hyperprolactinemia." | 1.28 | Thyrotropin alpha- and beta-subunit responses to thyrotropin-releasing hormone and domperidone in normal subjects and in patients with microprolactinomas. ( Beck-Peccoz, P; Conti, A; Faglia, G; Medri, G; Persani, L, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pinto, LP | 1 |
| Hanna, FW | 1 |
| Evans, LM | 1 |
| Davies, JS | 1 |
| John, R | 1 |
| Scanlon, MF | 2 |
| Valensi, P | 1 |
| Combes, ME | 1 |
| Perret, G | 1 |
| Attali, JR | 1 |
| Sawers, HA | 1 |
| Robb, OJ | 1 |
| Walmsley, D | 1 |
| Strachan, FM | 1 |
| Shaw, J | 1 |
| Bevan, JS | 2 |
| Lu, F | 1 |
| Wu, H | 1 |
| Zhang, K | 1 |
| Li, D | 1 |
| Webster, J | 1 |
| Page, MD | 1 |
| Richards, SH | 1 |
| Douglas-Jones, AG | 1 |
| Persani, L | 1 |
| Beck-Peccoz, P | 1 |
| Medri, G | 1 |
| Conti, A | 1 |
| Faglia, G | 1 |
| Ciccarelli, E | 1 |
| Ghigo, E | 1 |
| Miola, C | 1 |
| Gandini, G | 1 |
| Muller, EE | 1 |
| Camanni, F | 1 |
7 other studies available for domperidone and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia.
Topics: Adult; Domperidone; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Middle Aged; Pituitary | 2003 |
TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
Topics: Adult; Domperidone; Empty Sella Syndrome; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pit | 1996 |
An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia.
Topics: Adolescent; Adult; Domperidone; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Magnetic R | 1997 |
[Domperidone and hyperprolactinemia].
Topics: Adult; Domperidone; Female; Gastrointestinal Agents; Humans; Hyperprolactinemia; Middle Aged; Pituit | 1998 |
Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
Topics: Adult; Domperidone; Female; Follow-Up Studies; Humans; Hypophysectomy; Male; Middle Aged; Neoplasm R | 1992 |
Thyrotropin alpha- and beta-subunit responses to thyrotropin-releasing hormone and domperidone in normal subjects and in patients with microprolactinomas.
Topics: Adult; Domperidone; Dopamine; Female; Follicle Stimulating Hormone; Glycoprotein Hormones, alpha Sub | 1991 |
Long-term follow-up of 'cured' prolactinoma patients after successful adenomectomy.
Topics: Adenoma; Adrenalectomy; Adult; Domperidone; Dopamine Antagonists; Female; Follow-Up Studies; Humans; | 1990 |